+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Evolutionary Diversity as a Source for Anticancer Molecules

  • Book

  • September 2020
  • Elsevier Science and Technology
  • ID: 5007938

Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms. The book goes over the isolation of anticancer agents and the technologyenabled screening process used to develop anticancer drugs. The book also includes discussion of the nutraceuticals and natural products derived from invertebrates that can be used as part of cancer treatment.

Evolutionary Diversity as a Source for Anticancer Molecules also deals with some of the current challenges in the prevention of cancer as well as the side effects of conventional drugs used for cancer patients. This book is a valuable resource for cancer researchers, oncologists, biotechnologists, pharmacologists, and any member of the biomedical field interested in understanding more about natural products with anticancer potential.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Preface1. Evolutionary mechanism for biosynthesis of diversemolecules2. Impact of ploidy changes on secondary metabolitesproductions in plants3. Effect of climate change on plant secondary metabolism:An ecological perspective4. Isolation and characterization of bioactive compounds fromnatural resources: Metabolomics and molecular approaches5. Single-celled bacteria as tool for cancer therapy6. Metabolic pathways for production of anticancercompounds in cyanobacteria7. Prophyletic origin of algae as potential repository ofanticancer compounds8. Metabolic versatility of fungi as a source for anticancercompounds9. Structural information of natural product metabolites inbryophytes10. Landscape of natural product diversity in land-plants assource for anticancer molecules11. Anticancer natural product from marine invertebrates12. Melatonin: A scientific journey from the discoveryin bovine pineal gland to a promising oncostatic agent:An evolutionary perspective13. Spice up your food for cancer prevention: Cancerchemo-prevention by natural compounds fromcommon dietary spices14. Significance of nutraceuticals in cancer therapy15. Common techniques and methods for screening of naturalproducts for developing of anticancer drugsIndex

Authors

Akhileshwar Kumar Srivastava CSIR-Central Food Technological Research Institute, Mysore, India. Dr. Akhileshwar Kumar Srivastava works as a Research Associate (ICMR) in CSIR-Central Food Technological Research Institute, Mysore, India. In his eight years of research, he has published approximately 20 research articles and book chapters in international and national journals of repute. His research specialization is primarily in the area of pharmacognosy with genetics, metabolomics, bioinformatics, and molecular biology-associated targeting cancer diseases. In addition, he has studied at Augusta University (formerly, Georgia Regents University) in Augusta, GA, United States on a J-1 Exchange Scholar Visa and at Ben-Gurion University, Israel. He is also a life member fellow in Indian Science Congress and Agriculture, Nutrition and Health Academy, United Kingdom. Vinod Kumar Kannaujiya Assistant professor, Department of Botany, MMV, Banaras Hindu University, India.
MSc and PhD degrees, Botany from the Centre of Advanced Study in Botany, Banaras Hindu University. Dr. Vinod Kumar Kannaujiya is an assistant professor in the Department of Botany, MMV, Banaras Hindu University, India. He earned MSc and PhD degrees in Botany from the Centre of Advanced Study in Botany, Banaras Hindu University. He has been working on the ultraviolet stress response of cyanobacteria including value-added enzymes, proteins, pigments, and natural compounds. He has been awarded with prestigious fellowships from the Council of Scientific and Industrial Research, New Delhi, India. He has also been awarded the Dr. D.S. Kothari Post-Doctoral Fellowship from University Grant Commission, New Delhi, India, and he has received a UGC-Startup project grant from UGC, New Delhi, India. Dr. Kannaujiya is a life member fellow of the Indian Photobiology Society. Thus far, Dr. Kannaujiya has published over 40 original research papers, reviews, and book chapters. Rajesh Kumar Singh Research Associate, Centre of Experimental Medicine and Surgery at Banaras Hindu University, India. Dr. Rajesh Kumar Singh is currently working as a Research Associate in Banaras Hindu University. His research focus is pharmacognosy, reverse pharmacology, drug design and discovery, extraction & isolation of natural products, cell culture, and handling of different rodents. He has published several research articles in reputable journals over the course of his career. At present, he is involved in developing an Indian origin cell line and screening drugs of natural origin for the treatment of gallbladder cancer. Divya Singh Scientist, Central Sericultural Research and Training Institute, Mysore, India. Dr. Divya Singh is presently working as a scientist in Central Sericultural Research and Training Institute, Mysore, India. Her research specialization is primarily in genetics, proteomics, metabolomics, toxicology, bioinformatics, and molecular biological evaluation in various in vivo and in vitro plant models to elucidate the physiological changes and evaluate the DNA damage potency. She has published more
than 10 research articles including book chapters. In addition, she is also a life member fellow of Indian Science Congress.